N-[(4S,10R,13S,16S)-8-(cyclopropylmethyl)-13-[(4-methoxyphenyl)methyl]-10-methyl-4-(2-methylpropyl)-6,9,12,15-tetraoxo-2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-trien-16-yl]-2-oxo-1,3-dihydroimidazole-4-carboxamide
C38H49N7O8 — CID 138806118
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(4S,10R,13S,16S)-8-(cyclopropylmethyl)-13-[(4-methoxyphenyl)methyl]-10-methyl-4-(2-methylpropyl)-6,9,12,15-tetraoxo-2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-trien-16-yl]-2-oxo-1,3-dihydroimidazole-4-carboxamide
N-[(4S,10R,13S,16S)-8-(cyclopropylmethyl)-13-[(4-methoxyphenyl)methyl]-10-methyl-4-(2-methylpropyl)-6,9,12,15-tetraoxo-2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-trien-16-yl]-2-oxo-1,3-dihydroimidazole-4-carboxamide (PubChem CID 138806118) has the molecular formula C38H49N7O8 and a molecular weight of 731.85 g/mol. Its IUPAC name is N-[(4S,10R,13S,16S)-8-(cyclopropylmethyl)-13-[(4-methoxyphenyl)methyl]-10-methyl-4-(2-methylpropyl)-6,9,12,15-tetraoxo-2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-trien-16-yl]-2-oxo-1,3-dihydroimidazole-4-carboxamide.
Molecular Properties
| Compound Name | N-[(4S,10R,13S,16S)-8-(cyclopropylmethyl)-13-[(4-methoxyphenyl)methyl]-10-methyl-4-(2-methylpropyl)-6,9,12,15-tetraoxo-2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-trien-16-yl]-2-oxo-1,3-dihydroimidazole-4-carboxamide |
|---|---|
| PubChem CID | 138806118 |
| Molecular Formula | C38H49N7O8 |
| Molecular Weight | 731.85 g/mol |
| Exact Mass | 731.36 |
| IUPAC Name | N-[(4S,10R,13S,16S)-8-(cyclopropylmethyl)-13-[(4-methoxyphenyl)methyl]-10-methyl-4-(2-methylpropyl)-6,9,12,15-tetraoxo-2-oxa-5,8,11,14-tetrazabicyclo[16.2.2]docosa-1(20),18,21-trien-16-yl]-2-oxo-1,3-dihydroimidazole-4-carboxamide |
| SMILES | COc1ccc(C[C@@H]2NC(=O)[C@@H](NC(=O)c3c[nH]c(=O)[nH]3)Cc3ccc(cc3)OC[C@H](CC(C)C)NC(=O)CN(CC3CC3)C(=O)[C@@H](C)NC2=O)cc1 |
| InChI | InChI=1S/C38H49N7O8/c1-22(2)15-27-21-53-29-13-9-25(10-14-29)17-31(43-36(49)32-18-39-38(51)44-32)35(48)42-30(16-24-7-11-28(52-4)12-8-24)34(47)40-23(3)37(50)45(19-26-5-6-26)20-33(46)41-27/h7-14,18,22-23,26-27,30-31H,5-6,15-17,19-21H2,1-4H3,(H,40,47)(H,41,46)(H,42,48)(H,43,49)(H2,39,44,51)/t23-,27+,30+,31+/m1/s1 |
| InChIKey | HROLVRUSRWKWGW-XHCLBPLVSA-N |
| XLogP | 1.45 |
| TPSA | 203.82 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 53 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 731.85 |
| LogP ≤ 5 | 1.45 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'crown_ether', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138806118 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.